MedTrace Logo

Continuous Intraosseous Vascular Access Over 48 Hours

NCT01866475 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2024-04-09

Study results available
· View outcomes & findings →

Summary

A prospective study to determine the safety of intraosseous (IO) access for a period up to 48 hours in healthy adult volunteers and volunteers with a history of mild to moderate renal disease and/or controlled diabetes.

Conditions

  • Intraosseous Vascular Access

Interventions

DEVICE

EZ-IO

To have an EZ-IO placed up to 48 hours

Sponsors & Collaborators

  • Vidacare Corporation

    lead INDUSTRY

Principal Investigators

  • Emanuel DeNoia, MD · ICON Early Phase Services

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01866475 on ClinicalTrials.gov